Novo Nordisk AS
A3EU6F
DK0062498333 //
Quelle: CPH Equities: 19:23:01
240,65 DKK
Kurs
Kurs
1,07%
Diff. Vortag in %
Diff. Vortag in %
224,25 DKK
52 Wochen Tief
52 Wochen Tief
533,40 DKK
52 Wochen Hoch
52 Wochen Hoch
- Eher Negativ
- Seit dem 27.03.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 09.04.2026 0 Monate | 09.04.2026 | 0 Monate | 240,65 332 | 240,65 | 332 | 37,959692 | UBS | ||
| Novo Nordisk AS | 01.04.2026 0 Monate | 01.04.2026 | 0 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | BARCLAYS | ||
| Novo Nordisk AS | 31.03.2026 12 Monate | 31.03.2026 | 12 Monate | 240,65 263 | 240,65 | 263 | 9,287347 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 30.03.2026 0 Monate | 30.03.2026 | 0 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | BARCLAYS | ||
| Novo Nordisk AS | 29.03.2026 0 Monate | 29.03.2026 | 0 Monate | 240,65 250 | 240,65 | 250 | 3,885311 | JPMORGAN | ||
| Novo Nordisk AS | 0 Monate | 0 Monate | 240,65 275 | 240,65 | 275 | 14,273842 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.03.2026 0 Monate | 26.03.2026 | 0 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | BARCLAYS | ||
| Novo Nordisk AS | 25.03.2026 0 Monate | 25.03.2026 | 0 Monate | 240,65 250 | 240,65 | 250 | 3,885311 | JPMORGAN | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 240,65 300 | 240,65 | 300 | 24,662373 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 240,65 250 | 240,65 | 250 | 3,885311 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 240,65 260 | 240,65 | 260 | 8,040723 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 240,65 400 | 240,65 | 400 | 66,216497 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 240,65 250 | 240,65 | 250 | 3,885311 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 240,65 400 | 240,65 | 400 | 66,216497 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 240,65 332 | 240,65 | 332 | 37,959692 | UBS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 240,65 340 | 240,65 | 340 | 41,284022 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 240,65 275 | 240,65 | 275 | 14,273842 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 240,65 340 | 240,65 | 340 | 41,284022 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 240,65 275 | 240,65 | 275 | 14,273842 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 240,65 250 | 240,65 | 250 | 3,885311 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 240,65 340 | 240,65 | 340 | 41,284022 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 240,65 340 | 240,65 | 340 | 41,284022 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 240,65 340 | 240,65 | 340 | 41,284022 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 240,65 340 | 240,65 | 340 | 41,284022 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 240,65 400 | 240,65 | 400 | 66,216497 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 240,65 275 | 240,65 | 275 | 14,273842 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 240,65 360 | 240,65 | 360 | 49,594847 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 240,65 360 | 240,65 | 360 | 49,594847 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 240,65 360 | 240,65 | 360 | 49,594847 | BARCLAYS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 240,65 332 | 240,65 | 332 | 37,959692 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 240,65 475 | 240,65 | 475 | 97,38209 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 240,65 332 | 240,65 | 332 | 37,959692 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 240,65 360 | 240,65 | 360 | 49,594847 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 240,65 390 | 240,65 | 390 | 62,061085 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | JEFFERIES |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 240,65 436 | 240,65 | 436 | 81,175982 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 240,65 415 | 240,65 | 415 | 72,449616 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 240,65 360 | 240,65 | 360 | 49,594847 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 240,65 390 | 240,65 | 390 | 62,061085 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 240,65 390 | 240,65 | 390 | 62,061085 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 240,65 360 | 240,65 | 360 | 49,594847 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 240,65 415 | 240,65 | 415 | 72,449616 | BERENBERG | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 240,65 475 | 240,65 | 475 | 97,38209 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 240,65 390 | 240,65 | 390 | 62,061085 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 240,65 400 | 240,65 | 400 | 66,216497 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 240,65 400 | 240,65 | 400 | 66,216497 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 240,65 360 | 240,65 | 360 | 49,594847 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 240,65 475 | 240,65 | 475 | 97,38209 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 240,65 475 | 240,65 | 475 | 97,38209 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 240,65 295 | 240,65 | 295 | 22,584667 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 240,65 295 | 240,65 | 295 | 22,584667 | UBS | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 240,65 350 | 240,65 | 350 | 45,439435 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 240,65 352 | 240,65 | 352 | 46,270517 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 240,65 400 | 240,65 | 400 | 66,216497 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 240,65 295 | 240,65 | 295 | 22,584667 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 240,65 270 | 240,65 | 270 | 12,196135 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 240,65 375 | 240,65 | 375 | 55,827966 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 240,65 315 | 240,65 | 315 | 30,895491 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 240,65 475 | 240,65 | 475 | 97,38209 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 240,65 353 | 240,65 | 353 | 46,686059 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 240,65 475 | 240,65 | 475 | 97,38209 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 240,65 500 | 240,65 | 500 | 107,770621 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 240,65 500 | 240,65 | 500 | 107,770621 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 240,65 290 | 240,65 | 290 | 20,50696 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 240,65 375 | 240,65 | 375 | 55,827966 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 240,65 391 | 240,65 | 391 | 62,476626 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 240,65 | 240,65 | -- | DZ BANK |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 240,65 315 | 240,65 | 315 | 30,895491 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 240,65 400 | 240,65 | 400 | 66,216497 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 240,65 475 | 240,65 | 475 | 97,38209 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 240,65 600 | 240,65 | 600 | 149,324745 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 240,65 | 240,65 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 240,65 315 | 240,65 | 315 | 30,895491 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 240,65 315 | 240,65 | 315 | 30,895491 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 240,65 600 | 240,65 | 600 | 149,324745 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 240,65 391 | 240,65 | 391 | 62,476626 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 240,65 540 | 240,65 | 540 | 124,392271 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 240,65 290 | 240,65 | 290 | 20,50696 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 240,65 500 | 240,65 | 500 | 107,770621 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 240,65 500 | 240,65 | 500 | 107,770621 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 240,65 290 | 240,65 | 290 | 20,50696 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 240,65 340 | 240,65 | 340 | 41,284022 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 240,65 540 | 240,65 | 540 | 124,392271 | BERNSTEIN RESEARCH |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 06.05.2026 | Bericht zum 1. Quartal Novo Nordisk A/S: First quarter 2026 | Novo Nordisk A/S: First quarter 2026 |
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Min
Discount in %
Max
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
Abstand zum Basispreis in %
Max
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Min
KO-Schwellenabstand in %
Max
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M